Rebif

Rebif is indicated for the treatment of:

·       - Patients with relapsing forms of multiple sclerosis

·      - Patients who have experienced a single clinical event likely to be a first sign of multiple sclerosis and have Magnetic Resonance Imaging (MRI) features consistent with multiple sclerosis.